NOVEL MUTATION (V75T) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONFERS RESISTANCE TO 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE IN CELL-CULTURE

被引：122

作者：

LACEY, SF ^{[1
]}

LARDER, BA ^{[1
]}

机构：

[1] WELLCOME RES LABS,ANTIVIRAL THERAPEUT RES UNIT,BECKENHAM BR3 3BS,KENT,ENGLAND

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1994年 / 38卷 / 06期

关键词：

D O I：

10.1128/AAC.38.6.1428

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We have selected a human immunodeficiency virus type 1 (HIV-1) mutant strain with a moderate (sevenfold) level of resistance to the nucleoside analog 2',3'-didehydro-2',3'-dideoxythymidine (D4T or stavudine). After serial passage of the HXB2 strain of HIV-1 in MT4 cells, a novel mutation involving two nucleotide substitutions in codon 75 of the viral reverse transcriptase, altering valine to threonine, was seen. When introduced into a wild-type HIV-1 background by site-directed mutagenesis, the T-75 mutation conferred cross-resistance to the dideoxynucleosides dideoxyinosine and dideoxycytosine as well as to 2',3'-didehydro-2',3'-dideoxycytosine.

引用

页码：1428 / 1432

页数：5

共 29 条

[1] ANDERSON R, 1993, 33RD INT C ANT AG CH
[2] BALZARINI J, 1989, J BIOL CHEM, V264, P6127
[3] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
BOUCHER, CAB
OSULLIVAN, E
MULDER, JW
RAMAUTARSING, C
KELLAM, P
DARBY, G
LANGE, JMA
GOUDSMIT, J
LARDER, BA
[J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
[4] BRETTSMITH H, 1992, 8 INT C AIDS AMST
[5] FISCHER AG, 1985, NATURE, V316, P262
[6] GENERATION OF DRUG-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY INVITRO PASSAGE IN INCREASING CONCENTRATIONS OF 2',3'-DIDEOXYCYTIDINE AND 2',3'-DIDEOXY-3'-THIACYTIDINE
GAO, Q
GU, ZX
HISCOTT, J
DIONNE, G
WAINBERG, MA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) : 130 - 133
[7] INFECTION OF HTLV-III/LAV IN HTLV-I-CARRYING CELLS MT-2 AND MT-4 AND APPLICATION IN A PLAQUE-ASSAY
HARADA, S
KOYANAGI, Y
YAMAMOTO, N
[J]. SCIENCE, 1985, 229 (4713) : 563 - 566
[8] HITCHCOCK M J M, 1991, Antiviral Chemistry and Chemotherapy, V2, P125
[9] 5TH MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE CONTRIBUTES TO THE DEVELOPMENT OF HIGH-LEVEL RESISTANCE TO ZIDOVUDINE
KELLAM, P
BOUCHER, CAB
LARDER, BA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) : 1934 - 1938
[10] RECOMBINANT VIRUS ASSAY - A RAPID, PHENOTYPIC ASSAY FOR ASSESSMENT OF DRUG SUSCEPTIBILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
KELLAM, P
LARDER, BA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) : 23 - 30

← 1 2 3 →